Join Ausbiz Capital for our next Investor Connect event, where ASX-listed CEOs will share insights from their businesses alongside an expert market update focused on the major global forces shaping investment markets today.

From geopolitical tensions and ongoing conflicts to rising fuel prices, inflation and, shifting economic policy, this session will explore how recent world events are impacting markets and what investors should watch out for in the months ahead.

Investor Connect brings companies and investors together to share insights, strategies, and performance updates. These briefings give you the opportunity to hear directly from ASX-listed CEOs and ask your questions.

Our events are about real connection between companies and investors, so don't forget to submit your questions in the registration form. You're also welcome to post questions during the live event.
  • Amplia Therapeutics (ASX:ATX) Mkt Cap $78m A clinical-stage drug development company focused on oral inhibitors of Focal Adhesion Kinase (FAK) for the treatment of cancer and fibrotic diseases.
  • Cogstate (ASX:CGS) Mkt Cap $384m An Australian neuroscience technology company developing digital cognitive testing used by pharmaceutical companies, researchers and healthcare providers around the world.
  • Orthocell Ltd (ASX:OCC) Mkt Cap $278m Orthocell is a regenerative medicine company dedicated to the development of breakthrough products for the treatment of musculoskeletal disorders.
  • Telix Pharmaceuticals (ASX:TLX) Mkt Cap $3.7b Telix is a global, commercial-stage biopharmaceutical company focused on the development of diagnostic and therapeutic (‘theranostic’) products using targeted radiation.
  • Economic & Market Update -  Shaw and Partners With more than 17 years’ experience, Adam Dawes has a deep-seated knowledge of the Australian Stock Market and specialises in constructing and managing Australian equity portfolios for high-net-worth and sophisticated investors.
  • 1635385080-a9fe751ea03808de
    ausbiz
Share